{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:34:25Z","timestamp":1792668865383,"version":"4.5.0"},"reference-count":57,"publisher":"Georg Thieme Verlag KG","issue":"05","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hamostaseologie"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Antithrombin (AT) deficiency is a high-risk thrombophilia and a rare condition. The risk of venous thromboembolism (VTE) is increased in AT-deficient women during pregnancy and the postpartum period and is especially high in women with a prior history of VTE. A thorough assessment of VTE risk is recommended in pregnant AT-deficient women, comprising the degree and type of AT deficiency, genetic mutations, personal and family history, and additional preexisting or pregnancy-specific risk factors. Due to a lack of adequate study data, there is limited guidance on the management of AT deficiency in pregnancy, including the need for prophylactic anticoagulation, the appropriate dose of low-molecular-weight heparin (LMWH), and the role of AT substitution. LMWH is the medication of choice for the pharmacological prophylaxis and treatment of VTE in pregnancy. Patients with a history of VTE should receive full-dose LMWH during pregnancy and the postpartum period. AT concentrates are a treatment option when anticoagulation is withheld in potentially high-risk events such as childbirth, bleeding, or surgery and in cases of acute VTE despite the use of therapeutic dose anticoagulation. Women with AT deficiency should be counseled at specialized centers for coagulation disorders or vascular medicine, and close cooperation between obstetricians and anesthesiologists is warranted before delivery and during the peripartum period.<\/jats:p>","DOI":"10.1055\/a-1841-0399","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T23:30:12Z","timestamp":1667431812000},"page":"320-329","source":"Crossref","is-referenced-by-count":29,"title":["Management of Antithrombin Deficiency in Pregnancy"],"prefix":"10.1055","volume":"42","author":[{"given":"Christina","family":"Hart","sequence":"additional","affiliation":[{"name":"Department of Haematology and Oncology, University Hospital Regensburg, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannelore","family":"Rott","sequence":"additional","affiliation":[{"name":"Gerinnungszentrum Rhein\/Ruhr, Duisburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Heimerl","sequence":"additional","affiliation":[{"name":"Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Linnemann","sequence":"additional","affiliation":[{"name":"Division of Angiology, University Hospital Regensburg - University Center of Vascular Medicine, Regensburg, Bavaria, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2022,11,2]]},"reference":[{"issue":"11","key":"ref1","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.5858\/2002-126-1326-AD","article-title":"Antithrombin deficiency: issues in laboratory diagnosis","volume":"126","author":"K Kottke-Marchant","year":"2002","journal-title":"Arch Pathol Lab Med"},{"issue":"11","key":"ref2","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.biochi.2010.05.011","article-title":"Molecular mechanisms of antithrombin-heparin regulation of blood clotting proteinases. A paradigm for understanding proteinase regulation by serpin family protein proteinase inhibitors","volume":"92","author":"S T Olson","year":"2010","journal-title":"Biochimie"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3109\/00365516509077290","article-title":"Thrombophilia caused by inheritable deficiency of blood antithrombin","volume":"17","author":"O Egeberg","year":"1965","journal-title":"Scand J Clin Lab Invest"},{"issue":"06","key":"ref4","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/00001721-199212000-00008","article-title":"Congenital thrombophilia among patients with venous thromboembolism","volume":"3","author":"E Melissari","year":"1992","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"01","key":"ref5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1365-2141.1994.tb04878.x","article-title":"Prevalence of antithrombin deficiency in the healthy population","volume":"87","author":"R C Tait","year":"1994","journal-title":"Br J Haematol"},{"issue":"05","key":"ref6","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.thromres.2015.03.010","article-title":"Natural anticoagulants deficiency and the risk of venous thromboembolism: a meta-analysis of observational studies","volume":"135","author":"M N Di Minno","year":"2015","journal-title":"Thromb Res"},{"issue":"04","key":"ref7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1055\/s-0038-1625983","article-title":"Risk of venous thrombosis in antithrombin deficiency: a systematic review and bayesian meta-analysis","volume":"44","author":"F N Croles","year":"2018","journal-title":"Semin Thromb Hemost"},{"issue":"06","key":"ref8","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/MBC.0000000000000933","article-title":"Successful treatment of a massive sinus thrombosis in a Chinese woman with antithrombin III deficiency: a case report and review of the literature","volume":"31","author":"F Shang","year":"2020","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"05","key":"ref9","first-page":"e8383","article-title":"Not just another headache: cerebral venous sinus thrombosis in a patient with isolated antithrombin III deficiency","volume":"12","author":"D Findakly","year":"2020","journal-title":"Cureus"},{"issue":"03","key":"ref10","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s13760-020-01580-3","article-title":"Cerebral venous sinus thrombosis in child with antithrombin deficiency and novel SERPINC1 variant","volume":"121","author":"H Yokota","year":"2021","journal-title":"Acta Neurol Belg"},{"issue":"03","key":"ref11","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/jgh.12085","article-title":"Prevalence of inherited antithrombin, protein C, and protein S deficiencies in portal vein system thrombosis and Budd-Chiari syndrome: a systematic review and meta-analysis of observational studies","volume":"28","author":"X Qi","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"issue":"S 01","key":"ref12","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1055\/s-0037-1619781","article-title":"Arterial thrombosis in homozygous antithrombin deficiency","volume":"32","author":"M Olivieri","year":"2012","journal-title":"Hamostaseologie"},{"issue":"03","key":"ref13","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1160\/TH08-09-0583","article-title":"Antithrombin Cambridge II (A384S) supports a role for antithrombin deficiency in arterial thrombosis","volume":"101","author":"V Rold\u00e1n","year":"2009","journal-title":"Thromb Haemost"},{"issue":"07","key":"ref14","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1182\/blood.V92.7.2353","article-title":"Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families","volume":"92","author":"I Martinelli","year":"1998","journal-title":"Blood"},{"issue":"06","key":"ref15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/17474086.2019.1611424","article-title":"Management of antithrombin deficiency: an update for clinicians","volume":"12","author":"C Bravo-P\u00e9rez","year":"2019","journal-title":"Expert Rev Hematol"},{"issue":"06","key":"ref16","first-page":"577","article-title":"Human Gene Mutation Database (HGMD): 2003 update","volume":"21","author":"P D Stenson","year":"2003","journal-title":"Hum Mutat"},{"issue":"09","key":"ref17","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1177\/1060028016651276","article-title":"Issues in the diagnosis and management of hereditary antithrombin deficiency","volume":"50","author":"K A Bauer","year":"2016","journal-title":"Ann Pharmacother"},{"issue":"06","key":"ref18","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1160\/TH16-08-0635","article-title":"Thrombotic risk according to SERPINC1 genotype in a large cohort of subjects with antithrombin inherited deficiency","volume":"117","author":"M Alhenc-Gelas","year":"2017","journal-title":"Thromb Haemost"},{"issue":"05","key":"ref19","first-page":"885","article-title":"Classic thrombophilic gene variants","volume":"114","author":"P M Mannucci","year":"2015","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref20","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/jth.13252","article-title":"Founder effect is responsible for the p.Leu131Phe heparin-binding-site antithrombin mutation common in Hungary: phenotype analysis in a large cohort","volume":"14","author":"R Gindele","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/jth.14648","article-title":"Recommendations for clinical laboratory testing for antithrombin deficiency; Communication from the SSC of the ISTH","volume":"18","author":"E M Van Cott","year":"2020","journal-title":"J Thromb Haemost"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0049-3848(81)90045-1","article-title":"Antithrombin III levels during heparin therapy","volume":"24","author":"A K Rao","year":"1981","journal-title":"Thromb Res"},{"issue":"05","key":"ref23","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/ijlh.12528","article-title":"Comparison of the effect of the anti-Xa direct oral anticoagulants apixaban, edoxaban, and rivaroxaban on coagulation assays","volume":"38","author":"R Gosselin","year":"2016","journal-title":"Int J Lab Hematol"},{"issue":"04","key":"ref24","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1111\/ijlh.12319","article-title":"The effects of dabigatran on lupus anticoagulant, diluted plasma thrombin time, and other specialized coagulation assays","volume":"37","author":"Y A Kim","year":"2015","journal-title":"Int J Lab Hematol"},{"issue":"S 01","key":"ref25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/ijlh.13196","article-title":"The effect of DOACs on laboratory tests and their removal by activated carbon to limit interference in functional assays","volume":"42","author":"T Exner","year":"2020","journal-title":"Int J Lab Hematol"},{"issue":"01","key":"ref26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1055\/s-0039-1677840","article-title":"Laboratory diagnostics in thrombophilia","volume":"39","author":"B Linnemann","year":"2019","journal-title":"Hamostaseologie"},{"issue":"10","key":"ref27","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.2165\/00003495-200767100-00005","article-title":"Hereditary and acquired antithrombin deficiency: epidemiology, pathogenesis and treatment options","volume":"67","author":"P S Maclean","year":"2007","journal-title":"Drugs"},{"issue":"04","key":"ref28","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2008.02921.x","article-title":"Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study","volume":"6","author":"E R Pomp","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"03","key":"ref29","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/AOG.0b013e31820ce2db","article-title":"Risk of venous thromboembolism during the postpartum period: a systematic review","volume":"117","author":"E Jackson","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"14","key":"ref30","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa1311485","article-title":"Risk of a thrombotic event after the 6-week postpartum period","volume":"370","author":"H Kamel","year":"2014","journal-title":"N Engl J Med"},{"issue":"05","key":"ref31","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1055\/a-1132-0750","article-title":"Prevention of venous thromboembolism during pregnancy and the puerperium with a special focus on women with hereditary thrombophilia or prior VTE-Position Paper of the Working Group in Women's Health of the Society of Thrombosis and Haemostasis (GTH)","volume":"40","author":"C Hart","year":"2020","journal-title":"Hamostaseologie"},{"issue":"03","key":"ref32","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00277-013-1892-0","article-title":"Prevention, management and extent of adverse pregnancy outcomes in women with hereditary antithrombin deficiency","volume":"93","author":"N Rogenhofer","year":"2014","journal-title":"Ann Hematol"},{"issue":"04","key":"ref33","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.1016\/S2352-3026(20)30007-7","article-title":"Risk of pregnancy-related venous thromboembolism and obstetrical complications in women with inherited type I antithrombin deficiency: a retrospective, single-centre, cohort study","volume":"7","author":"M Abbattista","year":"2020","journal-title":"Lancet Haematol"},{"issue":"02","key":"ref34","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1055\/s-0038-1645218","article-title":"Thrombosis and pregnancy in congenital deficiencies in AT III, protein C or protein S: study of 78 women","volume":"63","author":"J Conard","year":"1990","journal-title":"Thromb Haemost"},{"issue":"06","key":"ref35","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1055\/s-0038-1642528","article-title":"Thrombosis during pregnancy and surgery in patients with congenital deficiency of antithrombin III, protein C, protein S","volume":"71","author":"V De Stefano","year":"1994","journal-title":"Thromb Haemost"},{"issue":"S 01","key":"ref36","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/jth.12266","article-title":"Thrombosis in women: what are the knowledge gaps in 2013?","volume":"11","author":"S Middeldorp","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"02","key":"ref37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2141.2005.05847.x","article-title":"Thrombophilia in pregnancy: a systematic review","volume":"132","author":"L Robertson","year":"2006","journal-title":"Br J Haematol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"e691S","DOI":"10.1378\/chest.11-2300","article-title":"VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"S M Bates","year":"2012","journal-title":"Chest"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"j4452","DOI":"10.1136\/bmj.j4452","article-title":"Pregnancy, thrombophilia, and the risk of a first venous thrombosis: systematic review and bayesian meta-analysis","volume":"359","author":"F N Croles","year":"2017","journal-title":"BMJ"},{"issue":"09","key":"ref40","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/j.1538-7836.2012.04858.x","article-title":"Low borderline plasma levels of antithrombin, protein C and protein S are risk factors for venous thromboembolism","volume":"10","author":"P Bucciarelli","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref41","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1160\/TH12-09-0663","article-title":"Antithrombin levels and the risk of a first episode of venous thromboembolism: a case-control study","volume":"109","author":"M N Di Minno","year":"2013","journal-title":"Thromb Haemost"},{"issue":"19","key":"ref42","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1182\/blood-2016-03-703728","article-title":"Hereditary risk factors for thrombophilia and probability of venous thromboembolism during pregnancy and the puerperium","volume":"128","author":"A Gerhardt","year":"2016","journal-title":"Blood"},{"issue":"06","key":"ref43","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1001\/archinternmed.2008.589","article-title":"The value of family history as a risk indicator for venous thrombosis","volume":"169","author":"I D Bezemer","year":"2009","journal-title":"Arch Intern Med"},{"issue":"03","key":"ref44","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1160\/TH13-01-0077","article-title":"How I treat heterozygous hereditary antithrombin deficiency in pregnancy","volume":"110","author":"K Bramham","year":"2013","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref45","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/1753495X17741025","article-title":"Severe antithrombin deficiency in pregnancy: achieving adequate anticoagulation","volume":"12","author":"B Pearson-Stuttard","year":"2019","journal-title":"Obstet Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.thromres.2019.01.007","article-title":"Monitoring of heparins in antithrombin-deficient patients","volume":"175","author":"F N Croles","year":"2019","journal-title":"Thromb Res"},{"issue":"03","key":"ref47","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.thromres.2006.10.006","article-title":"Monitoring unfractionated heparin (UFH) therapy: which anti-factor Xa assay is appropriate?","volume":"120","author":"V Ignjatovic","year":"2007","journal-title":"Thromb Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2147\/IJWH.S43190","article-title":"Prevention and treatment of venous thromboembolism in pregnancy in patients with hereditary antithrombin deficiency","volume":"5","author":"A H James","year":"2013","journal-title":"Int J Womens Health"},{"issue":"04","key":"ref49","first-page":"343","article-title":"Recombinant human antithrombin in pregnant patients with hereditary antithrombin deficiency: integrated analysis of clinical data","volume":"33","author":"M J Paidas","year":"2016","journal-title":"Am J Perinatol"},{"key":"ref50","first-page":"9261351","article-title":"Management of venous thromboembolism in patients with hereditary antithrombin deficiency and pregnancy: case report and review of the literature","volume":"2017","author":"M Refaei","year":"2017","journal-title":"Case Rep Hematol"},{"issue":"06","key":"ref51","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S1701-2163(15)30569-7","article-title":"Venous thromboembolism and antithrombotic therapy in pregnancy","volume":"36","author":"W S Chan","year":"2014","journal-title":"J Obstet Gynaecol Can"},{"issue":"22","key":"ref52","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1182\/bloodadvances.2018024802","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy","volume":"2","author":"S M Bates","year":"2018","journal-title":"Blood Adv"},{"issue":"01","key":"ref54","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/AOG.0000000000002706","article-title":"ACOG Practice Bulletin No. 196: Thromboembolism in pregnancy","volume":"132","author":"American College of Obstetricians and Gynecologists' Committee on Practice Bulletins\u2014Obstetrics","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"02","key":"ref55","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1024\/0301-1526\/a000504","article-title":"Treatment of pregnancy-associated venous thromboembolism - position paper from the Working Group in Women's Health of the Society of Thrombosis and Haemostasis (GTH)","volume":"45","author":"B Linnemann","year":"2016","journal-title":"Vasa"},{"issue":"05","key":"ref56","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1024\/0301-1526\/a000559","article-title":"German S3 guideline for the prevention of venous thromboembolism updated Comment on Vasa Supplement 92","volume":"45","author":"S Haas","year":"2016","journal-title":"Vasa"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.thromres.2017.05.017","article-title":"Management of hereditary antithrombin deficiency in pregnancy","volume":"157","author":"A H James","year":"2017","journal-title":"Thromb Res"},{"issue":"26","key":"ref58","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1182\/blood.2019002927","article-title":"How I treat patients with hereditary antithrombin deficiency","volume":"134","author":"I Pabinger","year":"2019","journal-title":"Blood"}],"container-title":["H\u00e4mostaseologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1841-0399.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T23:33:46Z","timestamp":1667432026000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1841-0399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":57,"journal-issue":{"issue":"05","published-online":{"date-parts":[[2022,11,2]]},"published-print":{"date-parts":[[2022,10]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1841-0399","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0720-9355","2567-5761"],"issn-type":[{"value":"0720-9355","type":"print"},{"value":"2567-5761","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}